Enveda Biosciences Closes $68-million Combined Series B Equity and Debt Financing (December 21, 2022) BOULDER, Colo.–(BUSINESS WIRE)–Enveda Biosciences today announced that it has closed a $68-million equity and debt financing.

Wave Life Sciences to receive $170M upfront in new partnership with GSK to develop a large number of candidates (December 13, 2022) | By Tyler Patchen. Wave Life Sciences has

Amgen Is Said to Agree to Buy Horizon at $26 Billion Value (December 12, 2022) | By Katie Roof, Michelle F Davis, and Dinesh Nair. Amgen agrees to pay around

Paragon Therapeutics Launches First Spinout, Apogee Therapeutics, to Advance Novel Therapies for Inflammatory and Immunological Conditions (December 07, 2022) | By Paragon Therapeutics. Apogee emerges with $169 million to expand

Roche Doubles Down on Jnana’s RAPID Platform in $2B Deal (November 15, 2022) | By Alex Keown. It’s been a lucrative Tuesday for Jnana Therapeutics after it forged a second

Sanofi taps into Insilico Medicine’s AI platform in deal worth up to $1.2bn (November 10, 2022) | By Rachel Arthur. Sanofi and Insilico Medicine have announced a multi-year, multi-target strategic

Juvena Therapeutics Raises $41M in Series A Funding November 8, 2022 Juvena Therapeutics, a Redwood City, CA-based biotechnology company, raised $41M in Series A funding. The round was led by

Normunity Announces $65 Million Series a Financing to Expand the Frontier of Precision Immuno-Oncology With Immune Normalizer Therapies October 25, 2022 07:00 AM Eastern Daylight Time BOSTON & WEST HAVEN,

Roche and Hookipa Tie Up in KRAS Inhibitor Deal Valued at Potential $950M (October 20, 2022) | By Alex Keown. Roche and Austria-based Hookipa Pharma tied up a licensing and

Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google’s Calico (October 12, 2022) | By Paul Schloesser. A small California biotech emerged from stealth last